RWRuiyong Wang

Ruiyong Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ruiyong Wang has a total of 101 co-authors. Here are the top co-authors by number of shared publications:

  • Junbiao Chang

    State Key Laboratory of Antiviral Drugs, Pingyuan Laboratory, NMPA Key Laboratory for Research and Evaluation of Innovative Drug, School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang, Henan 453007, China

    25 shared publications
  • Zhigang Li

    College of Chemistry and Molecular Engineering, Zhengzhou University, Zhengzhou, 450001, China

    11 shared publications
  • Ning Wang

    College of Chemistry and Molecular Engineering, Zhengzhou University, Zhengzhou, China

    10 shared publications
  • Xinxin Han

    College of Chemistry and Molecular Engineering, Zhengzhou University, Zhengzhou, China

    10 shared publications
  • Miao Zhang

    College of Chemistry, Pingyuan Laboratory (Zhengzhou), Zhengzhou UniversityUniversity, Zhengzhou 450001, China

    8 shared publications
  • Wenquan Yu

    College of Chemistry Pingyuan Laboratory State Key Laboratory of Antiviral Drugs Zhengzhou University Zhengzhou 450001 China

    8 shared publications

Latest Publications

  • Discovery and Mechanistic Elucidation of Spiro[Indole‐3,2′‐Pyrrolidine] Derivatives as Inhibitors of the SARS‐CoV‐2 Main Protease

    by Jinyue Li, Nuoya Wang, Wenquan Yu, Shuyang Wang, Xiaoyu Chang, Ruiyong Wang

    The main protease (Mpro) is a cysteine protease that plays an indispensable role in the replication process of coronaviruses. As a promising target for the development of anticoronavirus drugs, the screening and evaluation of inhibitors against Mpro are core steps in the drug discovery pipeline. In this study, 30 spiro[indole‐3,2'‐pyrrolidine] derivatives were evaluated for their inhibitory activity against Mpro using a FRET‐based cleavage assay. Three compounds ( 2t , 2u , and 2v ) exhibited promising inhibitory effects, among which compound 2u showed the most potent activity. Fluorescence quenching spectroscopy revealed that the quenching mechanism of Mpro by 2u involved both static and dynamic components, with static quenching playing a dominant role. Thermodynamic analysis indicated that the binding of 2u to Mpro is a spontaneous process, primarily driven by hydrophobic interactions. Microscale thermophoresis measurements yielded a dissociation constant ( K d ) of 8.91 ± 2.29 µM for the 2u ‐Mpro complex. Molecular docking studies provided visual insights into the interaction modes. Multiple biophysical assays suggest that 2t , 2u , and 2v bind predominantly through non‐covalent interactions. This study provides valuable clues for the discovery of Mpro inhibitors against SARS‐CoV‐2.

  • Discovery and Mechanistic Characterization of Tetrahydroisoquinoline Derivatives as Inhibitors of SARS‐CoV‐2 Main Protease

    by Wenhui Zhang, Nuoya Wang, Wenquan Yu, Yahong Chen, Xiaoyu Chang, Ruiyong Wang

    SARS‐CoV‐2 main protease (Mpro) is an enzyme for viral replication and an target for antiviral drugs due to its evolutionary conservation across coronaviruses and the absence of closely related human homologs. Tetrahydroisoquinoline (THIQ) derivatives represent a structurally diverse class of nitrogen‐containing heterocycles with proven versatility in medicinal chemistry. Thirty newly synthesized compounds, including THIQ‐based molecules and structurally related amine analogs, were evaluated for their inhibitory activity against Mpro. Six compounds exhibited significant inhibitory potency (IC 50 < 50 μM). Compound 3ia, containing nitro and para ‐bromophenyl groups, was the most active candidate with an IC 50 of 6.61 μM. Fluorescence quenching and thermodynamic analyses revealed that the interactions between active compounds and Mpro occurred predominantly via static quenching. Results demonstrated that compound binding induced conformational changes in Mpro. Differential scanning fluorimetry (DSF) showed that all active compounds increased the thermal stability of Mpro, and microscale thermophoresis (MST) confirmed high‐affinity binding ( K d = 25.92 μM for 3ia ). Molecular docking further revealed that the THIQ scaffold of 3ia inserts into the Mpro substrate‐binding pocket, forming π–sulfur interactions with the catalytic Cys145. This work confirms THIQ as a promising lead scaffold for Mpro inhibitors and supports the structure‐based design of improved anticoronavirus candidates.

  • Synthesis and Binding Affinity Insights of 2‐Phenyl‐1 H ‐Benzimidazole Inhibitors Targeting FTO by Spectroscopic Characterization and Molecular Docking

    by Jing Wang, Yahong Chen, Ruiyong Wang

    In this work, we designed and synthesized 28 structural analogs of 2‐phenyl‐1 H ‐benzimidazole. Three of these compounds exhibited stronger binding affinity to FTO, as determined by fluorescence spectroscopy. The results indicate that the binding process is spontaneous and occurs primarily via a static quenching mechanism, driven mainly by hydrogen bonding and van der Waals forces. The interactions of these three lead analogs with FTO were further investigated using UV–visible absorption spectroscopy, circular dichroism spectroscopy, and molecular docking. The docking results are consistent with the thermodynamic data. Among the 28 synthesized derivatives, compounds 7 , 8 , and 11 exhibited the strongest predicted binding affinities toward FTO and were selected for further spectroscopic and molecular docking studies. In preliminary biological evaluation, compound 7 showed antiproliferative activity against K562 cells with an IC 50 value of 18.11 μM. This study provides valuable insights into the interaction mechanisms between 2‐phenyl‐1 H ‐benzimidazole analogs and FTO.

  • Synthesis and Evaluation of Thiosemicarbazone Inhibitors for SARS‐CoV‐2 Mpro by Spectroscopy and Microscale Thermophoresis

    by Leyao Chen, Xinluan Lv, Xiaoyu Chang, Ruiyong Wang

    The SARS‐CoV‐2 pandemic has spurred global efforts to develop therapeutic approaches. The main protease (Mpro) of SARS‐CoV‐2 is crucial for viral replication and a key target for therapeutic development. In this study, 22 thiosemicarbazone derivatives were synthesized. Enzyme activity assays showed compound 3c exhibited obvious inhibition of Mpro, with an IC 50 value of 3.89 μM. The interaction mechanisms between thiosemicarbazone derivatives and Mpro were investigated using synchronous fluorescence, three‐dimensional fluorescence, and circular dichroism spectroscopy. The fluorescence results indicate that static quenching is predominant. The equilibrium dissociation constant ( K d ) of 2.3 μM between 3c and Mpro was obtained by microscale thermophoresis. This K d value demonstrates the binding affinity of 3c for Mpro, consistent with the spectral results. Meanwhile, the binding modes and stability of thiosemicarbazone derivatives with Mpro were evaluated through molecular docking and molecular dynamics simulations, which also confirmed the stable binding between compound 3c and Mpro. This study provides valuable insights into the interaction mechanism between thiosemicarbazone derivatives and Mpro and provides clues for the design of Mpro inhibitors.


  • Investigation of the Interaction Between 4‐Thiazolidinone Derivatives and SARS‐CoV‐2 Mpro Using Spectroscopy and Microscale Thermophoresis

    by Leyao Chen, Nuoya Wang, Xiaoyu Chang, Ruiyong Wang

    Since the outbreak of COVID‐19, one of the strategies used to search for potential drugs has been to screen inhibitors of SARS‐CoV‐2 Mpro. This work investigated the inhibitory effects of 4‐thiazolidinone derivatives on main protease (Mpro) using various methods, including enzyme activity assays, enzyme kinetics, spectroscopy experiments, molecular docking simulations, microscale thermophoresis, and cytotoxicity tests. Compound 3a demonstrated the best inhibition effect among the compounds tested, with IC 50 = 2.36 ± 0.36 µM and K i = 1.72 µM. The trifluoromethyl group in 3a might enhance its inhibition ability. Interactions between the 4‐thiazolidinone derivatives and Mpro resulted in fluorescence quenching primarily through static quenching. Thermodynamic analysis indicated that the interaction forces are mainly hydrogen bonds and van der Waals forces. Spectral results revealed that the 4‐thiazolidinone derivatives affected the microenvironment of aromatic amino acid residues in Mpro and altered its secondary structure. Differential scanning fluorimetry was used to confirm the interaction between the 4‐thiazolidinone derivatives and Mpro. Results of microscale thermophoresis indicated that the K d between 3a and Mpro was 1.56 ± 0.24 µM. Molecular docking simulations provided a more intuitive visualization of the interaction forces. This study provides clues for screening novel Mpro inhibitors.


  • Investigation of Pyrrole Analogues Inhibition on Main Protease by Spectroscopic Analysis, Molecular Docking, and Enzyme Activity

    by Nuoya Wang, Leyao Chen, Wenjun Ye, Wenquan Yu, Xiaoyu Chang, Ruiyong Wang

    The main protease (Mpro) is a cysteine enzyme and represents a vital target for antiviral drug screening. In this work, 25 pyrrole derivatives were synthesized and screened by enzyme activity experiments. Results indicate that six pyrrole derivatives can bind to Mpro and have an inhibitory effect on Mpro. The binding mode involves a static quenching process. Among them, 1d exhibits the highest binding affinity. The interactions between pyrrole derivatives and Mpro are investigated by spectra and molecular docking. The interaction between 1d and Mpro is spontaneous and enthalpy‐driven. Hydrogen bonding is identified as the primary binding force for 1d . Furthermore, nitro groups are important for the binding between pyrrole analogs and Mpro. This study elucidates the mechanism of interactions and provides direction and valuable insights for developing novel Mpro inhibitors.


  • Investigating the Inhibition of Diindolylmethane Derivatives on SARS‐CoV‐2 Main Protease

    by Wenjin Li, Xiaoyu Chang, Hang Zhou, Wenquan Yu, Ruiyong Wang, Junbiao Chang

    The SARS‐CoV‐2 main protease (Mpro) is an essential enzyme that promotes viral transcription and replication. Mpro conserved nature in different variants and its nonoverlapping nature with human proteases make it an attractive target for therapeutic intervention against SARS‐CoV‐2. In this work, the interaction mechanism between Mpro and diindolylmethane derivatives was investigated by molecular docking, enzymatic inhibition assay, UV–vis, fluorescence spectroscopy, and circular dichroism spectroscopy. Results of IC 50 values show that 1p (9.87 μM) was the strongest inhibitor for Mpro in this work, which significantly inhibited the activity of Mpro. The binding constant (4.07 × 10 5 Lmol −1 ), the quenching constant (5.41 × 10 5 Lmol −1 ), and thermodynamic parameters indicated that the quenching mode of 1p was static quenching, and the main driving forces between 1p and Mpro are hydrogen bond and van der Waals force. The influence of molecular structure on the binding is investigated. Chlorine atoms and methoxy groups are favorable for the diindolylmethane derivative inhibitors of Mpro. This work confirms the changes in the microenvironment of Mpro by 1p , and provides clues for the design of potential inhibitors.